Epigenetic modification-related mechanisms of hepatocellular carcinoma resistance to immune checkpoint inhibition

Hepatocellular carcinoma (HCC) constitutes most primary liver cancers and is one of the most lethal and life-threatening malignancies globally. Unfortunately, a substantial proportion of HCC patients are identified at an advanced stage that is unavailable for curative surgery. Thus, palliative thera...

全面介紹

書目詳細資料

發表在:	Frontiers in Immunology
Main Authors:	Shengwei Tao, Shuhang Liang, Taofei Zeng, Dalong Yin
格式:	Article
語言:	英语
出版:	Frontiers Media S.A. 2023-01-01
主題:	tumor immunotherapy immune checkpoint inhibitors hepatocellular carcinoma (HCC) epigenetic modification immune resistance mechanisms
在線閱讀:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.1043667/full